Tag: biologic drug costs

Global Biosimilar Markets: Europe vs United States - How Regulations Shape Adoption and Cost Savings

Europe led the world in biosimilar adoption with clear regulations and early trust. The U.S. lagged due to legal barriers-but is now accelerating fast. Here’s how the two markets compare and what it means for patients and costs.